Event: October 21st 2014: New Trial Pathways and Better Patient Data – Speakers

Better Science, Better Health: New Trial Pathways and Better Patient Data

Speakers:

Edward Abrahams

President,
Personalized Medicine Coalition

Ifty Ahmed

CEO,
Pow Health

Mohammad Al-Ubaydli

CEO,
Patients Know Best®

James Anderson

Director of EU Industry & External Partnerships,
GSK

Andrea Beyer

Expert,
Benefit Risk Assessment

Richard Barker

Director,
CASMI

Jack Bowman

CEO,
Handle my Health

Finn Børlum Kristensen

Executive Director,
EUnetHTA

Helmut Brand

President,
International Forum Gastein

Wendy Currie

Editor in Chief,
Health Policy & Technology
Audencia, France

John Crawford

Healthcare Industry Leader,
IBM Europe

Hans-Georg Eichler

Senior Medical Officer,
European Medicines Agency

Laura Esserman

Breast Cancer Center Director (I-Spy)
University of California San Francisco

Gary Finnegan

Journalist, Editor and Author

George Freeman

Parliamentary Under Secretary of
State for Life Sciences,
UK Government

Pat Furlong

Founding President and CEO,
Parent Project Muscular Dystrophy

Sarah Garner

Associate Director, Research and Development,
National Institutes of Clinical Excellence

Michel Goldman

Executive Director,
IMI

Jeremy Haigh

European Chief Operating Officer, Research & Development
Amgen Ltd.

Joel Haspel

Director Strategy & Business
Development EMEA,
Oracle Health Sciences

Adam Heathfield

Senior Director, Global Health and Value Innovation Center,
Pfizer

Ryan Hohman

Managing Director, Policy & Public Affairs,
Friends of Cancer Research US

Alastair Kent

Director,
Genetic Alliance UK

Faraz Kermani

Senior Editor Europe,
Elsevier – The Pink Sheet

Yann Le Cam

CEO,
Eurordis

Sandrine Marreaud

Head of Medical and Pharmacovigilance Department,
EORTC

Jillian Oderkirk

Senior Analyst, Health Division,
OECD

Bettina Ryll

Founder,
Melanoma Patient Network Europe

Duane Schulhtess

Managing Director,
Vital Transformation

Cornelius Schmaltz

Deputy Head of Unit of the Fighting Infectious Diseases and Global
Epidemics unit, European Commission

Nathalie Seigneuret

Senior Scientific Project Manager,
Innovative Medicines Initiative (IMI)

Paolo Daniele Siviero

Head of Office Pharmaceutical Policy,
Italian Medicines Agency

Olga Solomon

Deputy Head of Unit,
DG Health and Consumers,
Medicinal products, authorisations – ema (D5), European Commission

Sir Richard Thompson

Immediate Past President,
Royal College of Physicians

Richard Torbett

Chief Economist,
EFPIA

Mark Trusheim

Visiting Scientist,
MIT Sloan School of Management
MIT Center for Biomedical Innovation

Bart Vannieuwenhuyse

Senior Director Health Information Sciences,
Janssen Pharmaceutical Companies
of Johnson and Johnson

Andrew Ward

Pharmaceuticals Correspondent,
Financial Times

Tim Williams

Head of Research,
Clinical Practice Research Datalink
(CPRD)

Geoff Wilson

HTA Task Force Leader,
COCIR

Stephen Whitehead

Chief Executive,
ABPI

In collaboration with:

2017-08-09T09:15:04+00:00